Description
Celgene
is
a
global_biopharmaceutical
company
leading
the
way
in
medical
innovation
to
help_patients
live
longer
better
lives
Our
purpose
as
a
company
is
to
discover
and
develop_therapies
that
will
change
the
course
of
human
health
We
value
our
passion
for
patients
quest
for
innovation
spirit
of
independence
and
love
of
challenge
With
a
presence
in
more
than
70_countries
-
and
growing
-
we
look
for
talented_people
to
grow
our
business
advance
our
science
and
contribute
to
our
unique_culture
Translational
Development
at
Celgene
A
role
of
Translational
Development
at
Celgene
is
to
provide
disease_specific
patient_selection
strategies
insights
into
target
engagement
and
downstream
phenotypic
effects
to
guide
and
support
early
phase
development
programs
and
late_clinical
development
programs
in
solid
tumors
including
but
not
limited
to
GBM
Lung
and
Pancreatic
Cancer
Development
of
deeper_understanding
of
the
biology
pathophysiology
oncogenic
microenvironment
and
immunological
influencers
in
these
disease
states
to
empower
existing
and
future
Celgene
assets
Translational
development
is
a
central
theme
of
many
pipeline
and
acquired
assets
at
Celgene
The
position
holder
will
be
expected
to
develop
a
large
matrix
of
internal
and
external_stakeholders
across
relevant
diseases
and
drug
MOAs
At
the
moment
the
drug
assets
span
IO
epigenetics
and
protein
homeostasis
but
since
we
have
a
highly
active
process
of
external
innovation
and
partnership
the
incumbent_must
demonstrate
the
ability
and
willingness
to
pick
up
new
areas
of
basic
and
applied
science
as
required
Position
Description
Leads
translational
disease
team
with
deep
disease
drug
development
and
business
knowledge
in
solid
tumors
Leads
and
oversees
execution
of
strategy
on
all
components
of
translational_development
approach
in
disease_area
including
but
not
limited
to
various_aspects
of
patient_selection
strategies
in
solid
tumors
and
translational_research
Liaises
with
key
Celgene
Research
and
Early
Development
thematic
centers
of
excellence
areas
including
protein
homeostasis
immune-oncology
bio-therapeutics
and
epigenetics
and
companion
diagnostics
group
to
help
formulate
and
execute
on
new
hypotheses
driving
new
clinical
biomarker
assays
for
unmet_need
segments
disease
strategy
for
new
targets
and
development
candidates
and
ensure
seamless
transition
of
patient_selection
strategies
beyond
Phase
1
Liaises
with
late_clinical
development
program
to
support
late_clinical
R
and
D
and
MAST
projects
Supports
regulatory
and
communication
needs
of
late
phase
compounds
and
approved
drugs
for
the
disease_area
Identifies
needs
gaps
and
translational
questions
and
applies_knowledge
across
all
disease
programs
and
assets
in
Celgene
portfolio
and
combinations
with
external
assets
Serves
as
translational
representative
on
Disease
Strategy
Team
and
interfaces
with
commercial
clinical
Project
leadership
and
regulatory
teams
to
define
patient
segments
of
unmet_need
based
on
rapidly_evolving
clinical
programs
and
commercial
landscape
Overall
manager
and
leader
of
disease
focused
scientific
team
who
delivers
on
research_lab
projects
Celgene
and
IIT
clinical_trial
projects
and
oversight
of
TD
scientists
in
the
disease_area
to
enable
decision_making
for
patient
stratification
identification
and
response
criteria
Leads
small
and
large
collaborations
with
academia
and
industry
partners
to
identify
biobanks
clinical_trials
and
existing
databases
to
collate
multi-parameter
genomic
and
clinical_datasets
to
mine
for
novel
biomarkers
of
unmet_need
patients
in
conjunction
with
computational
biologists
data_scientists
and
statisticians
Interfaces
with
common
functions
including
lab
head
to
coordinate_laboratory
projects
including
combinations
and
resistance
mechanisms
collection
and
maintenance
of
biobank
samples
for
assay
discovery
and
validation
across
disease_area
and
with
scientific
writer
to
address
regulatory
responses
Key
activities
will
also
include
working_closely
with
clinical
investigators
identifying_opportunities
for
translational
medicine
projects
delivering
high_quality
presentations
and
acting
as
an
internal
disease
expert
LI-CB1
Qualifications
MD
and
PhD
with
significant
immuno
oncology
and
solid
tumor
experience
Qualifications
MD
and
PhD
in
with
significant
immune
oncology
and
solid
tumor
experience
Exposure
to
working
within
or
interfacing
with
clinical
teams
Deep
disease
and
drug
development
knowledge
Expertise
in
the
integration
of
preclinical
research
and
clinical
drug
development
Ability
to
lead
basic
research
programs
as
well
as
development
and
execution
of
clinical
correlative
science
strategies
Management
experience
with
the
ability
to
set_priorities
direct
projects
and
implement
complex
strategies
and
work
on
cross-functional_teams
Highly
effective
teamwork
and
interpersonal_skills
and
the
ability
to
work
across
numerous
scientific
disciplines
Able
to
communicate
in
both
written
and
verbal
format
complex
and
detailed
information
in
a
manner
that
enhances
understanding
and
ensures
that
the
recipient
will
be
able
to
apply
the
information
presented
Celgene
is
committed
to
equal_opportunity
in
the
terms
and
conditions
of
employment
for
all
employees
and
job
applicants_without
regard
to
race
color
religion
sex
sexual_orientation
age
gender_identity
or
gender_expression
national_origin
disability
or
veteran_status
Celgene
complies
with
all
applicable
national
state
and
local_laws
governing_nondiscrimination
in
employment
as
well
as
employment_eligibility
verification_requirements
of
the
Immigration
and
Nationality
Act
All
applicants_must
have
authorization
to
work
for
Celgene
in
the
US